Wells Fargo’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-32,479
| Closed | -$749K | – | 7326 |
|
|
2020
Q4 | $749K | Buy |
32,479
+22,979
| +242% | +$530K | ﹤0.01% | 4164 |
|
|
2020
Q3 | $97K | Sell |
9,500
-1,628
| -15% | -$16.6K | ﹤0.01% | 5083 |
|
|
2020
Q2 | $166K | Sell |
11,128
-10,240
| -48% | -$153K | ﹤0.01% | 4830 |
|
|
2020
Q1 | $260K | Buy |
21,368
+9,225
| +76% | +$112K | ﹤0.01% | 4356 |
|
|
2019
Q4 | $192K | Buy |
12,143
+7,643
| +170% | +$121K | ﹤0.01% | 4817 |
|
|
2019
Q3 | $55K | Buy |
+4,500
| New | +$55K | ﹤0.01% | 5254 |
|